비스테로이드성 항염증제(NSAID) 원료의약품(API) 시장 규모, 점유율, 성장 분석 : 화학 분류별, 제조원별, 약품 순도/등급별, 용도별, 지역별 - 산업 예측(2026-2033년)

Global Nonsteroidal Anti-Inflammatory Apis Market size was valued at USD 26.0 Billion in 2024 and is poised to grow from USD 27.56 Billion in 2025 to USD 43.93 Billion by 2033, growing at a CAGR of 6.0% during the forecast period (2026-2033).

The global nonsteroidal anti-inflammatory APIs market is primarily driven by the increasing demand for NSAID medications, spurred by population aging and the rising incidence of chronic inflammatory and musculoskeletal disorders. This market, which supplies active pharmaceutical ingredients like ibuprofen, naproxen, and diclofenac to generic formulators, significantly impacts the cost, quality, and availability of frontline analgesics. The industry has transitioned from vertically integrated pharmaceutical companies to API manufacturers predominantly in India and China due to patent expirations and subsequent generic supply increases. Cost dynamics, driven by genericization and regulatory scrutiny, play a crucial role in shaping market growth. AI is enhancing R&D efficiency by expediting discovery cycles and optimizing processes, fostering the development of greener, more efficient production methods, ultimately bolstering market resilience and capacity expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nonsteroidal Anti-Inflammatory Apis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nonsteroidal Anti-Inflammatory Apis Market Segments Analysis

Global nonsteroidal anti-inflammatory apis market is segmented by chemical class, manufacturing source, drug purity/grade, application type and region. Based on chemical class, the market is segmented into Propionic Acid Derivatives, Acetic Acid Derivatives, Enolic Acid Derivatives and Selective COX-2 Inhibitors. Based on manufacturing source, the market is segmented into In-house Manufacturing and Contract Manufacturing. Based on drug purity/grade, the market is segmented into USP/EP Standard Grade and High-Purity Research Grade. Based on application type, the market is segmented into Tablet & Capsule Formulations, Topical Gels & Patches and Injectable Solutions. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Nonsteroidal Anti-Inflammatory Apis Market

One of the key market drivers for the global nonsteroidal anti-inflammatory drugs (NSAIDs) market is the rising prevalence of chronic inflammatory conditions and pain-related disorders. As the global population ages and lifestyle-related diseases increase, there is a heightened demand for effective pain management solutions. Additionally, the growing awareness of the benefits of NSAIDs for treating conditions such as arthritis, osteoarthritis, and other musculoskeletal disorders further propels market growth. The expansion of healthcare infrastructure and the increasing availability of advanced NSAID formulations also contribute to the growing adoption of these medications, making them a critical component of pain relief therapies.

Restraints in the Global Nonsteroidal Anti-Inflammatory Apis Market

One key market restraint for the global nonsteroidal anti-inflammatory agents (NSAIDs) market is the increasing incidence of adverse effects associated with long-term use of these medications. Patients often experience gastrointestinal issues, cardiovascular risks, and kidney problems, which can hinder patient compliance and limit the use of NSAIDs in managing pain and inflammation. Additionally, growing awareness among consumers of alternative therapies, such as biologics or natural supplements, may shift preferences away from NSAIDs. Regulatory scrutiny and guidelines urging caution in NSAID prescriptions further exacerbate these concerns, thereby restraining overall market growth and penetration in the healthcare landscape.

Market Trends of the Global Nonsteroidal Anti-Inflammatory Apis Market

The Global Nonsteroidal Anti-Inflammatory APIs market is witnessing a significant trend towards formulation and delivery innovation, driven by manufacturers aiming to enhance therapeutic profiles and improve patient adherence. The introduction of advanced delivery mechanisms such as controlled release matrices, transdermal patches, and modified release constructs fosters collaboration between drug developers and excipient specialists. This trend not only allows for the repositioning of established APIs into niche therapeutic areas but also helps extend product lifecycles without succumbing to price competition. A focus on patient-centered design and simplified administration methods is encouraging strategic partnerships and targeted marketing, ultimately influencing prescriber preferences and payer recognition across diverse markets.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Nonsteroidal Anti-inflammatory APIs Market Size by Chemical Class & CAGR (2026-2033)

• Market Overview
• Propionic Acid Derivatives
• Acetic Acid Derivatives
• Enolic Acid Derivatives
• Selective COX-2 Inhibitors

Global Nonsteroidal Anti-inflammatory APIs Market Size by Manufacturing Source & CAGR (2026-2033)

• Market Overview
• In-house Manufacturing
• Contract Manufacturing

Global Nonsteroidal Anti-inflammatory APIs Market Size by Drug Purity/Grade & CAGR (2026-2033)

• Market Overview
• USP/EP Standard Grade
• High-Purity Research Grade

Global Nonsteroidal Anti-inflammatory APIs Market Size by Application Type & CAGR (2026-2033)

• Market Overview
• Tablet & Capsule Formulations
• Topical Gels & Patches
• Injectable Solutions

Global Nonsteroidal Anti-inflammatory APIs Market Size & CAGR (2026-2033)

• North America (Chemical Class, Manufacturing Source, Drug Purity/Grade, Application Type)
  • US
  • Canada
• Europe (Chemical Class, Manufacturing Source, Drug Purity/Grade, Application Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Chemical Class, Manufacturing Source, Drug Purity/Grade, Application Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Chemical Class, Manufacturing Source, Drug Purity/Grade, Application Type)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Chemical Class, Manufacturing Source, Drug Purity/Grade, Application Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amgen Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol-Myers Squibb Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gilead Sciences, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hikma Pharmaceuticals PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aurobindo Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zydus Cadila
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lupin Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sandoz International GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations